Antiobesity effects of the β-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats
Jonathan D. Roth(Rutgers, The State University of New Jersey), David G. Parkes(Amplyx Pharmaceuticals (United States)), James L. Trevaskis, Chunli Lei, Todd Coffey, Jennifer Athanacio(Amplyx Pharmaceuticals (United States)), Julie Wilson, Christine M. Mack, C. Weyer(National Institutes of Health), Nicole C. Kesty(Theranostics (New Zealand))
Cited by 43
Related Papers
Bacterial outer membrane vesicles and the host–pathogen interaction
|Genes & Development|2005|953
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance
|Diabetologia|2000|791
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
|Proceedings of the National Academy of Sciences|2008|433
Amylin: Pharmacology, Physiology, and Clinical Potential
|Pharmacological Reviews|2015|395